Clare Hughes

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.

K. O'Byrne, J. Crown, A. Davies, 2017, Cellular Immunology.

Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer

L. Liotta, K. O'Byrne, V. Espina, 2020, Clinical Cancer Research.

Trastuzumab (T) and pertuzumab (P)-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) in tyrosine kinase inhibitor (TKI)-treated breast cancer (BC) cell lines.

K. O'Byrne, J. Crown, A. Davies, 2014 .